MEDIPOST raises KRW205bn (US$140m) in a convertible bond round led by SkyLake and Crescendo Equity Partners, with funds directed towards ongoing clinical trials.
Amount Raised
$140 Million
Round Type
Convertible Note
Investors
Description
MEDIPOST, a biotech company specializing in stem cell therapeutics, has successfully raised KRW205bn (US$140m) in growth capital. The round featured existing shareholders SkyLake Equity Partners and Crescendo Equity Partners, along with new investors. The funds will be used to support ongoing clinical trials for its flagship product, CARTISTEM®. BDA Partners served as the exclusive financial advisor to MEDIPOST in this transaction.
Quick answer
MEDIPOST raised $140 Million in a Convertible Note round, dated December 18, 2025. Investors: Skylake Equity Partners, Woori Private Equity Asset Management, Nh Private Equity and Crescendo Equity Partners.
- How much did MEDIPOST raise?
- MEDIPOST raised $140 Million in a Convertible Note round on December 18, 2025.
- Who invested in MEDIPOST?
- Skylake Equity Partners, Woori Private Equity Asset Management, Nh Private Equity and Crescendo Equity Partners are named as investors in this round.
- What does MEDIPOST do?
- MEDIPOST, Inc. is a leading commercial-stage biotechnology company specializing in the development of umbilical cord-derived stem cell therapies to treat inflammation-driven degenerative diseases.
- Where is MEDIPOST based and how big is it?
- Fundz records about 38 employees.
- Who are the decision-makers at MEDIPOST?
- Fundz holds 3 contacts at MEDIPOST, including the CEO & Managing Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Manufacturing around the same time
Companies in the same sectors as MEDIPOST that raised within 45 days of this round, from Fundz verified event records.
- Stellular Bio raised an undisclosed amount (Funding Round) on January 28, 2026.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- Virax Biolabs raised $5M (Post-IPO Equity) on December 3, 2025.
- SymPhysis Medical raised $1.3M (Grant) on November 26, 2025.
- Lineage Cell Therapeutics raised $21M (Funding Round) on November 12, 2025.
- CytoDyn raised $19M on January 30, 2026.
Who to call at MEDIPOST, and when
A new round usually means MEDIPOST is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MEDIPOST raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MEDIPOST, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MEDIPOST. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MEDIPOST raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
MEDIPOST raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.